RIANCORP PTY LTD

RianCorp is an Australian medical device manufacturer specializing in Low Level Laser Therapy (LLLT) products for clinical and home-based applications. The company's flagship product, the LTU-904 Laser Therapy Unit, is the only laser device cleared by the FDA for lymphedema treatment following breast cancer surgery. The device operates at 904 nm infrared wavelength and is classified as a Class 1 laser, eliminating eye safety requirements. RianCorp's LTU-904 is certified by the Australian TGA, FDA, CE Mark, and cleared by the Japanese Department of Agriculture. The company has completed the first randomized double-blind clinical trial of LLLT for lymphedema treatment globally, demonstrating clinical efficacy in approximately 30% of patients with measurable benefit in 50%. Beyond post-mastectomy lymphedema, the LTU-904 addresses slow-healing skin wounds, fibrous lesions, ligament sprains and strains, tendon injuries, and muscle soreness. The device is available for purchase or rental to both patients and healthcare professionals for clinic and home use across Australia, USA, China, and Europe. RianCorp emphasizes evidence-based clinical data and comprehensive customer support.